IMCR logo

Immunocore Holdings plc (IMCR) EBIT

Annual EBIT:

-$34.09M+$21.64M(+38.83%)
December 31, 2024

Summary

  • As of today, IMCR annual earnings before interest & taxes is -$34.09 million, with the most recent change of +$21.64 million (+38.83%) on December 31, 2024.
  • During the last 3 years, IMCR annual EBIT has risen by +$140.21 million (+80.44%).
  • IMCR annual EBIT is now at all-time high.

Performance

IMCR EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRincome statement metrics

Quarterly EBIT:

-$7.13M+$7.92M(+52.64%)
September 30, 2025

Summary

  • As of today, IMCR quarterly earnings before interest & taxes is -$7.13 million, with the most recent change of +$7.92 million (+52.64%) on September 30, 2025.
  • Over the past year, IMCR quarterly EBIT has increased by +$1.46 million (+17.01%).
  • IMCR quarterly EBIT is now -96.37% below its all-time high of -$3.63 million, reached on March 31, 2025.

Performance

IMCR Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRincome statement metrics

TTM EBIT:

-$45.08M+$1.46M(+3.14%)
September 30, 2025

Summary

  • As of today, IMCR TTM earnings before interest & taxes is -$45.08 million, with the most recent change of +$1.46 million (+3.14%) on September 30, 2025.
  • Over the past year, IMCR TTM EBIT has increased by +$23.22 million (+34.00%).
  • IMCR TTM EBIT is now -42.29% below its all-time high of -$31.68 million, reached on December 31, 2020.

Performance

IMCR TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

IMCR EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+38.8%+17.0%+34.0%
3Y3 Years+80.4%+32.7%+51.2%
5Y5 Years+78.8%--

IMCR EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+80.4%-96.4%+73.1%at high+51.2%
5Y5-Yearat high+80.4%-96.4%+86.0%-42.3%+75.7%
All-TimeAll-Timeat high+80.4%-96.4%+86.0%-42.3%+75.7%

IMCR EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
-$7.13M(+52.6%)
-$45.08M(+3.1%)
Jun 2025
-
-$15.05M(-314.6%)
-$46.54M(+2.1%)
Mar 2025
-
-$3.63M(+81.2%)
-$47.53M(+32.5%)
Dec 2024
-$34.09M(+38.8%)
-$19.27M(-124.4%)
-$70.37M(-3.0%)
Sep 2024
-
-$8.59M(+46.4%)
-$68.30M(+5.6%)
Jun 2024
-
-$16.04M(+39.4%)
-$72.36M(-3.2%)
Mar 2024
-
-$26.47M(-53.9%)
-$70.13M(-19.9%)
Dec 2023
-$55.74M(-57.1%)
-$17.20M(-36.0%)
-$58.48M(-10.1%)
Sep 2023
-
-$12.65M(+8.3%)
-$53.14M(-4.0%)
Jun 2023
-
-$13.80M(+6.9%)
-$51.08M(-10.9%)
Mar 2023
-
-$14.83M(-25.1%)
-$46.05M(+13.6%)
DateAnnualQuarterlyTTM
Dec 2022
-$35.47M(+79.6%)
-$11.86M(-11.9%)
-$53.30M(+42.3%)
Sep 2022
-
-$10.59M(-20.8%)
-$92.45M(+25.7%)
Jun 2022
-
-$8.77M(+60.3%)
-$124.46M(+24.1%)
Mar 2022
-
-$22.07M(+56.7%)
-$163.99M(+11.7%)
Dec 2021
-$174.31M(-51.8%)
-$51.01M(-19.7%)
-$185.76M(-11.6%)
Sep 2021
-
-$42.61M(+11.8%)
-$166.44M(-34.4%)
Jun 2021
-
-$48.30M(-10.2%)
-$123.83M(-64.0%)
Mar 2021
-
-$43.85M(-38.4%)
-$75.53M(-138.4%)
Dec 2020
-$114.82M(+28.5%)
-$31.68M(+10.5%)
-$31.68M(+10.5%)
Dec 2019
-$160.48M(-44.8%)
-$35.39M
-$35.39M
Dec 2018
-$110.82M
-
-

FAQ

  • What is Immunocore Holdings plc annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Immunocore Holdings plc?
  • What is Immunocore Holdings plc annual EBIT year-on-year change?
  • What is Immunocore Holdings plc quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Immunocore Holdings plc?
  • What is Immunocore Holdings plc quarterly EBIT year-on-year change?
  • What is Immunocore Holdings plc TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Immunocore Holdings plc?
  • What is Immunocore Holdings plc TTM EBIT year-on-year change?

What is Immunocore Holdings plc annual earnings before interest & taxes?

The current annual EBIT of IMCR is -$34.09M

What is the all-time high annual EBIT for Immunocore Holdings plc?

Immunocore Holdings plc all-time high annual earnings before interest & taxes is -$34.09M

What is Immunocore Holdings plc annual EBIT year-on-year change?

Over the past year, IMCR annual earnings before interest & taxes has changed by +$21.64M (+38.83%)

What is Immunocore Holdings plc quarterly earnings before interest & taxes?

The current quarterly EBIT of IMCR is -$7.13M

What is the all-time high quarterly EBIT for Immunocore Holdings plc?

Immunocore Holdings plc all-time high quarterly earnings before interest & taxes is -$3.63M

What is Immunocore Holdings plc quarterly EBIT year-on-year change?

Over the past year, IMCR quarterly earnings before interest & taxes has changed by +$1.46M (+17.01%)

What is Immunocore Holdings plc TTM earnings before interest & taxes?

The current TTM EBIT of IMCR is -$45.08M

What is the all-time high TTM EBIT for Immunocore Holdings plc?

Immunocore Holdings plc all-time high TTM earnings before interest & taxes is -$31.68M

What is Immunocore Holdings plc TTM EBIT year-on-year change?

Over the past year, IMCR TTM earnings before interest & taxes has changed by +$23.22M (+34.00%)
On this page